Why it was recalled
Subpotent drug
Product description
busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactured by Unichem Laboratories LTD., Ind, Area, Meerut Road, Ghazibad - 201 003, India Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816, NDC 29300-244-05.
Lot numbers, UPCs & expiration codes
Lot: ZBUL25001, Exp 12/31/2027
Where it was sold
USA Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0511-2026
- Classification
- Class III
- Status
- Ongoing
- Recall initiated
- Apr 13, 2026
- FDA report date
- May 13, 2026
- Quantity
- 10,875 Bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Unichem Pharmaceuticals USA Inc.
Original FDA data
Every field from FDA enforcement report D-0511-2026, exactly as published.
Show all FDA fields
- City
- East Brunswick
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 98728
- Address
- 1 Tower Center Blvd Ste 2200
- Code information
- Lot: ZBUL25001, Exp 12/31/2027
- Postal code
- 08816-1145
- Report date
- May 13, 2026
- Product type
- Drugs
- Recall number
- D-0511-2026
- Classification
- Class III
- Recalling firm
- Unichem Pharmaceuticals USA Inc.
- Product quantity
- 10,875 Bottles
- Reason for recall
- Subpotent drug
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactured by Unichem Laboratories LTD., Ind, Area, Meerut Road, Ghazibad - 201 003, India Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816, NDC 29300-244-05.
- Distribution pattern
- USA Nationwide
- Recall initiation date
- Apr 13, 2026
- Initial firm notification
- Letter
- Center classification date
- May 1, 2026